Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00960206 · ClinicalTrials.gov registry record · NA
ABC/Trident® Ceramic Post Approval Study
A NA study, sponsored by Stryker Orthopaedics.
- Completed
- Registry status
- NA
- Development phase
- 413
- Enrollment target
NCT00960206 is a NA study that has completed, run by Stryker Orthopaedics. The registered enrollment target is 413 participants.
The verdict
NCT00960206, a NA study, has completed, sponsored by Stryker Orthopaedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 413 participants
- Enrollment target
Study Summary
The purpose of the Post Approval Study of the ABC and Trident® systems is to continue to demonstrate the safety and efficacy of the alumina-on-alumina bearing surfaces combined with the appropriate shell in a cementless application.
Interventions
- DEVICE Trident® Ceramic Insert/Trident® AD HA Acetabular Shell
- DEVICE Alumina Insert/PSL® Microstructured Acetabular Shell or Secur-Fit® HA PSL® Acetabular Shell
- DEVICE OmniFit® Series II Insert/OmniFit® PSL® Microstructured Acetabular Shell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 413 participants |
| Start Date | 2003-03 |
| Est. Completion | 2010-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00960206
The ClinicalTrials.gov registry entry for NCT00960206 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 413 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Trident® Ceramic Insert/Trident® AD HA Acetabular Shell is the first listed.
NCT00960206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00960206 about?
NCT00960206 is a clinical study titled "ABC/Trident® Ceramic Post Approval Study". The purpose of the Post Approval Study of the ABC and Trident® systems is to continue to demonstrate the safety and efficacy of the alumina-on-alumina bearing surfaces combined with the appropriate shell in a cementless application.
What is the current status of trial NCT00960206?
This trial is currently completed. It is a NA study. The enrollment target is 413 participants. The study started on 2003-03. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00960206?
The interventions under investigation include: Trident® Ceramic Insert/Trident® AD HA Acetabular Shell (DEVICE), Alumina Insert/PSL® Microstructured Acetabular Shell or Secur-Fit® HA PSL® Acetabular Shell (DEVICE), OmniFit® Series II Insert/OmniFit® PSL® Microstructured Acetabular Shell (DEVICE).
Who is sponsoring clinical trial NCT00960206?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.